RxDoctor Payments Data

Robert Garrigus, PA

Physician Assistant · Maitland, FLNPI 1578910584

Payments from drug & device makers

$7,066in general payments, 2019–2025

Across 263 payments — averaging $26.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$986
  • E.r. Squibb & Sons, L.L.C.$671
  • Incyte Corporation$558
  • Johnson & Johnson$511
  • Sanofi$466
  • Galderma Laboratories, L.p.$433
  • plus $3K from 20 others

What the payments were for

  • Speaking & faculty fees$901%
  • Food & beverage$6,69395%
  • Education$2834%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,066 in reported general payments places this provider in the 90th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$191,883
Medicare patients
644
Services billed
3,372

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa19$389,787
Dupixent PenDupilumab53$222,732
Fluorouracil84$6,539
Ketoconazole335$4,751
Mometasone Furoate135$2,917
Clobetasol Propionate48$2,098
Betamethasone Dipropionate54$1,946
Metronidazole31$1,623
Mupirocin202$1,402
Triamcinolone Acetonide139$1,081
Doxycycline Hyclate88$854
Clindamycin Phosphate28$834
Hydrocortisone83$475
Fluconazole21$407
ValacyclovirValacyclovir Hcl22$345

Paid to pharmacies, not to this prescriber.

Other physician assistant in Maitland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →